IntroductionThymic carcinoma is a rare and invasive mediastinal neoplasm that often metastasizes. It constitutes a heterogeneous group of tumors that displays different biologic behavior and prognosis. The clinical prognostic factors and treatment of thymic carcinoma are not yet standardized.MethodsThirty patients with thymic carcinoma have been treated at Nagoya City University Hospital since 1983. The clinical and pathologic data of these patients were retrospectively reviewed. Thirteen cases were considered to be unresectable or inoperable and received chemotherapy or chemoradiotherapy. Seventeen cases underwent resection; total in 7 cases and subtotal in 10 cases. Postoperative irradiation was added as adjuvant therapy in the tolerable ...
Objective: Thymic carcinoma is a rare malignancy that has a poor prognosis and low 5-year survival. ...
Copyright © 2013 Hisao Higo et al. This is an open access article distributed under the Creative Com...
Thymoma has a variable long-term oncological outcome after surgical resection. Survival and tumor re...
IntroductionThymic carcinoma is a rare and invasive mediastinal neoplasm that often metastasizes. It...
SummaryThymic carcinoma is a rare but highly aggressive, easily metastasizing cancer derived from th...
Objective: Thymic carcinoma (TC) is a rare and invasive mediastinal tumor, with poor prognosis. Most...
Objective: Thymic carcinoma is a rare thymic neoplasm. It is more invasive and has a poorer prognosi...
Objective: Thymic carcinoma (TC) is a rare and invasive mediastinal tumor, with poor prognosis. Most...
Objective: Thymic carcinoma is a rare thymic neoplasm. It is more invasive and has a poorer prognosi...
OBJECTIVE: Prognosis of primary thymic carcinomas is poor due to advanced stage progression at diagn...
Introduction:Thymic carcinoma is a rare and aggressive thymic neoplasm. The European Society of Thor...
BackgroundThymic carcinomas are rare cancers with limited data regarding outcomes, particularly for ...
Thymoma and thymic carcinoma are an extremely heterogeneous group of neoplastic lesions with an exce...
Objectives: Thymic carcinoma is a rare neoplasm more invasive and with a poorer prognosis than ordin...
SummaryThymic carcinoma is a rare but highly aggressive, easily metastasizing cancer derived from th...
Objective: Thymic carcinoma is a rare malignancy that has a poor prognosis and low 5-year survival. ...
Copyright © 2013 Hisao Higo et al. This is an open access article distributed under the Creative Com...
Thymoma has a variable long-term oncological outcome after surgical resection. Survival and tumor re...
IntroductionThymic carcinoma is a rare and invasive mediastinal neoplasm that often metastasizes. It...
SummaryThymic carcinoma is a rare but highly aggressive, easily metastasizing cancer derived from th...
Objective: Thymic carcinoma (TC) is a rare and invasive mediastinal tumor, with poor prognosis. Most...
Objective: Thymic carcinoma is a rare thymic neoplasm. It is more invasive and has a poorer prognosi...
Objective: Thymic carcinoma (TC) is a rare and invasive mediastinal tumor, with poor prognosis. Most...
Objective: Thymic carcinoma is a rare thymic neoplasm. It is more invasive and has a poorer prognosi...
OBJECTIVE: Prognosis of primary thymic carcinomas is poor due to advanced stage progression at diagn...
Introduction:Thymic carcinoma is a rare and aggressive thymic neoplasm. The European Society of Thor...
BackgroundThymic carcinomas are rare cancers with limited data regarding outcomes, particularly for ...
Thymoma and thymic carcinoma are an extremely heterogeneous group of neoplastic lesions with an exce...
Objectives: Thymic carcinoma is a rare neoplasm more invasive and with a poorer prognosis than ordin...
SummaryThymic carcinoma is a rare but highly aggressive, easily metastasizing cancer derived from th...
Objective: Thymic carcinoma is a rare malignancy that has a poor prognosis and low 5-year survival. ...
Copyright © 2013 Hisao Higo et al. This is an open access article distributed under the Creative Com...
Thymoma has a variable long-term oncological outcome after surgical resection. Survival and tumor re...